Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients treated in Europe. - Université de Lille Accéder directement au contenu
Article Dans Une Revue Annals of Oncology Année : 2022

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients treated in Europe.

Dates et versions

hal-04337860 , version 1 (12-12-2023)

Identifiants

Citer

A. Lamarca, M. Morfouace, S. Tejpar, J. Oliveira, A. Capela, et al.. Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients treated in Europe.. Annals of Oncology, 2022, Annals of Oncology, ⟨10.1016/j.annonc.2022.07.006⟩. ⟨hal-04337860⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More